Answers are grounded in this paper and cite their sources.
Case report highlights thrombocytopenia due to immune reconstitution inflammatory syndrome in HIV, suggesting clinical challenges with treatment.
Highly active antiretroviral therapy (HAART) is imperative in managing human immunodeficiency virus (HIV) infections. HAART aims to inhibit viral replication and improve immunity. Antiretroviral therapy has led to significant improvement in CD4-T cell counts and reductions in viral load, leading to improved overall immune function, increased survival, and decreased frequency of opportunistic infections. Immune reconstitution inflammatory syndrome (IRIS) is defined by a hyperinflammatory immune response within six months of initial treatment with HAART. It is caused by dysregulated inflammatory immune responses against pathogens. Herein, we discuss a rare presentation of IRIS-induced thrombocytopenia in a 20-year-old Hispanic male patient.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: